2m 2m 2m 2m 2m 2m 2m
FENNEC PHARMA (FENC)
NASDAQ
$10.96-$0.005 (-0.05%)
Price as of Sep 11, 2026 7:30 PM EDT- $384.2MMarket Cap
- 25.11%1-Year Change
- BiotechnologyIndustry
FENNEC PHARMA (FENC)
$10.96-$0.005 (-0.05%)
FENC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.96 | ||
Change | -$0.34 (-3.01%) | ||
Open | $11.30 | ||
High | $11.51 | ||
Low | $10.85 | ||
Previous Close | $11.30 | ||
Volume | 249,928 | ||
30-Day Average Volume | 257,726 | ||
1-Week Change | -11.54% | ||
1-Month Change | -14.24% | ||
1-Year Change | 25.11% | ||
3-Year Change | 35.14% | ||
5-Year Change | 33.82% | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $75.8M | ||
Market Cap | $384.2M | ||
Enterprise Value | $343.0M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | $2.0M | ||
Free Cash Flow | $50,000.00 | ||
EBIT | $2.0M | ||
EBITDA | $2.0M | ||
Net Working Capital | $60.1M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 168 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 9 | ||
P/E | 219 | ||
PEG | 1 | ||
Price/Free Cash Flow | 7,685 | ||
Price/Operating Cash Flow | 7,685 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue